Bratha

Part 4.2 — The Enhanced Stack

17 min read

This is Part 4.2 in the Cognitive Enhancement Series (the experimental & prescription catalog). The full path:

Table of Contents

This is the edge of the map

Everything past Part 4.1 trades a steeply worse risk-to-reward ratio for diminishing returns. This article contains prescription medications (controlled substances in Malaysia), research chemicals with little or no long-term human safety data, and at least one compound (Dihexa) with a credible theoretical cancer mechanism and zero human trials. Doses are stated for harm reduction, not encouragement. The honest truth, stated once and meant: most people reading this never need to open this article. If the natural stack and a fixed sleep schedule are giving you four clean deep-work hours, you are already winning; adding research chemicals is buying risk you don’t need. Read this as a map of what exists and what it costs you, not a menu.

Read this before you read the compounds

This article is the catalog: what the experimental (Tier-3) and prescription (Tier-1) compounds are, organised by the same six pathways from the bio-circuit, so you can see each one as turning up a dial that already exists rather than bolting on something foreign. It deliberately answers only one question per compound, what it does and what it costs you, and leaves the other two questions to their own articles:

Where the other two questions live

  • “Should I even be here, and how do I escalate?” → Part 4.0 is the guiding framework: the one rule, the three levels, and the “do you even need this?” gate. If you haven't read 4.0, read it first; this catalog assumes you’ve already passed that gate.
  • “How do I actually mix one of these into my natural stack without breaking it?” → Part 4.3 is the mixing manual: which heavy-layer natural compounds to remove when you add an enhanced one (e.g. dropping caffeine but keeping L-theanine on a modafinil day), and which experimental compounds can run daily versus cyclically.

In other words: 4.0 tells you whether, this article tells you what, and 4.3 tells you how. Read this as a map of the territory, not a set of instructions, and don’t try to assemble a mix from this page alone, that’s what 4.3 is for.

The enhanced bio-circuit, pathway by pathway

1. Executive Function / ignition → the eugeroic & stimulant overlay

The natural ignition is caffeine + tyrosine. The enhanced version replaces the spark, not the fuel.

  • Modafinil / Armodafinil (Tier 1, prescription): the entrepreneur’s favourite, and the one with the most honest caveat. Strong when you’re sleep-deprived; only a modest attention benefit when you’re well-rested, with little effect on memory or motivation.1 So its single best use is exactly its label (defending output on a depleted day), which is a reason to fix sleep, not skip it. Layers cleanly on the natural base because it doesn’t deplete dopamine the way amphetamines do.
  • Methylphenidate / amphetamines (Tier 1, prescription): maximum drive, maximum tax: cardiovascular load and comedowns that crash your Peace pillar. Stacking amphetamine cardiovascular load on top of an active cycle is genuinely dangerous. If you need Tier-1 drive, the eugeroics are the lower-tax choice.
  • Bromantane (Tier 3): up-regulates the enzymes that synthesise dopamine rather than forcing a dump, for a smoother, “actogenic” profile with limited (mostly Russian) human data.

2. Memory / acetylcholine transmission → the racetam overlay

This is the classic nootropic class, and it sits directly on top of your natural choline layer.

  • Racetams (Tier 3, grey-market): piracetam, aniracetam, oxiracetam, pramiracetam: they modulate acetylcholine and AMPA-glutamate transmission, the substrate of learning. Phenylpiracetam is the stimulant standout (and WADA-banned, relevant if you compete). The honest evidence picture: decades of use and a good safety record, but ==the benefit in healthy adults is thin; most positive data is in elderly or cognitively-impaired populations==, and meta-analyses of piracetam don’t show clear memory benefit over placebo even there.2 They demand choline, which your natural stack already supplies; that’s the synergy and the warning (run them without the base and you get the headache, not the focus).
  • Donepezil / Galantamine (Tier 1, prescription): the heavy acetylcholinesterase brake from Part 3.0. An Alzheimer’s drug on a healthy brain is a sledgehammer: reserve-only, if ever, and never stacked on top of Huperzine (double-braking → cholinergic toxicity).

3. Neurogenesis / BDNF → the peptide overlay (handle with care)

The natural neurogenesis layer is Lion’s Mane (and Polygala as the ceiling-breaker). The enhanced versions are far more potent, and far less proven.

  • Noopept (Tier 3): up-regulates BDNF and NGF in animal models; widely used at low doses (10–30 mg), generally well-tolerated, but with limited human data.3 The most “reasonable” rung on this ladder.
  • Semax (Tier 3, peptide): a Russian nasal-spray peptide reported to spike BDNF and protect tissue. Interesting, minimal Western safety data.
  • Cerebrolysin (Tier 3, injectable): a parenteral neuropeptide mixture used clinically outside the West for stroke/dementia recovery. A serious medical drug, not a casual nootropic; listed for completeness, firmly not a self-experiment.
  • Dihexa (Tier 3, ⚠️ the hard stop):

    Dihexa: extraordinary potency, unacceptable unknowns picomolar concentrations, the source of the viral "millions of times more potent than BDNF" claim (a cell-culture potency comparison, not a real-world effect size).1 But its mechanism is potentiation of HGF/c-Met signalling, and c-Met is an oncogene, frequently dysregulated in cancer. Exogenously cranking that pathway carries a real theoretical cancer risk. On top of that: no human clinical data on the parent compound, and a 2021 expression of concern over image integrity in the foundational research (not fully retracted as of 2026). This is the clearest "the juice is not worth the squeeze" compound in the entire series. It's included here for completeness (pretending it doesn't exist helps no one), but the honest recommendation is don't. If you want a stronger BDNF push, exhaust Lion's Mane → Polygala → (maybe) Noopept first, and stop there.

    Dihexa is an angiotensin-IV-derived peptide that drives synaptogenesis at

4. Glutamate / neuroprotection → the shield you add because you’re enhancing

This pathway gets more important the heavier you go, not less.

  • Memantine (Tier 1, prescription): the NMDA-receptor shield from Part 3.1. If you’re running heavy stimulants or eugeroics regularly, glutamate excitotoxicity is the long-term cost, and Memantine buffers it. The trade-off: it can slightly blunt the acute edge of a high-stimulant day, so it’s a preservation choice, not a performance one.

5. Neurosteroids → the enhanced lifter’s hidden variable

Covered fully in Part 3.1, and it belongs here because the enhanced part of your life is what creates the problem: an active cycle suppresses upstream pregnenolone/DHEA, producing brain fog that more testosterone won’t fix. The rule is unchanged. ==These are hormones: test, correct a demonstrated deficit under supervision, re-test==, never a blind “for focus” add.

6. State control → the enhanced calm layer

  • Buspirone (Tier 1): non-sedating, non-dependence-forming serotonergic anxiolytic; the clean prescription option for the flexibility pillar.
  • Selank (Tier 3, peptide): a Russian anxiolytic peptide that modulates inflammation (IL-6) and stabilises serotonin/GABA without sedation or dependence. Well-tolerated in limited data.
  • Phenibut (Tier 3) → the trap: profound calm, genuinely dangerous dependence and withdrawal (benzodiazepine-like). Never more than 1–2× a week, and most people can't hold that line. Listed only so you recognise the trap; recommended against.

The risk-and-tier matrix

CompoundPathwayTierThe specific risk to weigh
Modafinil / ArmodafinilExecutive Function1 (Rx)Modest in well-rested; controlled substance; headache/insomnia
Methylphenidate / AmphetaminesExecutive Function1 (Rx)Cardiovascular load (dangerous on cycle); dependence; comedown
BromantaneExecutive Function3Sparse human data (mostly Russian)
Racetams (piracetam family)Memory / ACh3Weak evidence in healthy adults; choline-dependent (headache)
PhenylpiracetamExecutive + Memory3Tolerance builds fast; WADA-banned
Donepezil / GalantamineMemory (brake)1 (Rx)Cholinergic side effects; sledgehammer for a healthy brain
NoopeptNeurogenesis3Limited human data; the “most reasonable” peptide rung
SemaxNeurogenesis3Minimal Western safety data
CerebrolysinNeurogenesis3 (inj.)Parenteral medical drug, not a casual nootropic
DihexaNeurogenesis3⚠️ c-Met oncogene mechanism; no human data; research-integrity concern; avoid
MemantineGlutamate / shield1 (Rx)Blunts acute edge; the protective trade-off
BuspironeState control1 (Rx)Slow onset; mild; clean option
SelankState control3Limited Western data
PhenibutState control3⚠️ Severe dependence/withdrawal; avoid

A Maximal Day: the fully-assembled vision

To make the whole architecture legible in one picture, here is the maximal day: the “maxed-out entrepreneurial mind” with every pathway driven and protected, woven together with the Performance Enhancement and Sleep series into a single integrated arc. It follows the gas-and-brakes day from Part 1.1: a calm bedrock, excitation in the produce-windows, deliberate inhibition into recovery.

This is a thought experiment, not a protocol; read this first

==This day deliberately breaks the “one lever at a time” rule to show the complete integrated picture in one frame.== Nobody should build to this directly, and almost nobody should build to it at all. It stacks prescription stimulants, a prescription SSRI, a GLP-1 agonist, research peptides, and anabolics simultaneously, a combined risk load far beyond anything justified by the “do you even need this?” gate. Treat it the way you’d treat a pro bodybuilder’s full chemical protocol in the PE series: useful for understanding how the pieces relate, not a shopping list. In real life you run a fraction of this (the natural base plus, at most, one enhanced lever), and you add anything new one at a time, measured. Several pieces below carry flags I’d weight heavily; read the honesty callout at the end.

Act I: The Bedrock (≈06:00–07:30)

 Morning sunlight + fasted Zone 2 cardio + sauna
        │
        ▼  suppress melatonin · clear residual adenosine · set the circadian clock
 Natural anandamide / endorphin / oxytocin wave  →  calm baseline before work
        │
        ▼  gut + micronutrient cofactors (P5P/B6, magnesium, zinc, iron, omega-3)
 The "factory" primed to build neurotransmitters from amino acids later

Peak performance starts by setting the landscape before the first email, with the foundational layer, not a pill. Bright light suppresses melatonin and clears sleep-inertia adenosine; fasted Zone 2 cardio plus heat releases a natural anandamide/endorphin wave that buffers cortisol; and the gut-plus-cofactor base (fermented foods, active B6/P5P, magnesium, zinc, iron, omega-3) is the catalyst engine that lets amino acids become dopamine, serotonin, and acetylcholine. (The hormonal-base layer, e.g. intranasal testosterone for a stable morning androgen curve, is a PE-series decision, not a cognitive one; it lives here only because a suppressed neurosteroid base is what causes “TRT brain fog.“)

Act II: The Excitatory Tunnel (≈08:00–13:00)

   HIGH DRIVE                    +              SUPPRESSED NOISE
(Dopamine: L-Tyrosine)                     (L-Theanine + balance)
(Acetylcholine: Alpha-GPC, held                    │
 by a small Huperzine brake)                       ▼
        └───────────────► CALM, DEEP, "TUNNEL-VISION" EXECUTION

This is the deep-work window, the tunnel-vision factor made concrete: raise the gas (Tyrosine for dopamine, Alpha-GPC for acetylcholine, held by a small Huperzine brake) and suppress the noise (L-Theanine), so you sit near your inverted-U peak instead of past it. The disciplined enhanced version keeps any stimulant low and clean (the principle is a small eugeroic dose rather than a heavy classical stimulant), paired with theanine, never a megadose that scatters you. Carbohydrate is kept light here only because, for some people, a heavy high-carb meal blunts morning focus (it’s individual, not a law).

Act III: Neural Repair (≈14:00–19:00)

 20-min power nap  →  flushes accumulated adenosine, resets capacity
        │
        ▼  resistance training (the PE-series workout)
 Post-training CNS fatigue  →  buffered by neurotrophic support (BDNF/NGF)

A short nap flushes adenosine and resets the afternoon. Then the day shifts from intellectual to physical work, and the training itself is a cognitive intervention, because exercise is the biggest natural BDNF lever there is. (Pre-workout anabolics like sublingual Anavar are, again, a PE-series choice, not a nootropic one.) Heavy training transiently fatigues the CNS; the neurotrophic peptides from Part 3.1 (Semax, Cerebrolysin) are positioned here to buffer that, though both are research/parenteral compounds with the caveats already noted.

Act IV: The Inhibitory Re-Feed (≈20:00–22:00)

 High-protein + evening carbohydrate
        │
        ▼  insulin shuttles amino acids to muscle; serotonin rises
 Excitatory drive winds DOWN  →  the brakes come on

Now the arc inverts: the goal is to stop, to turn the gas off. The evening carb re-feed is deliberate: insulin drives recovery and nudges a serotonin rise that signals the nervous system to slow. This is the inhibition half of the gas-and-brakes day, and it’s also where the Sleep series’ wind-down begins.

Act V: The Deep-Sleep Reset (≈22:00–06:00)

 GABA + L-Theanine (± 5-HTP)  →  dampen residual glutamate, stop racing thoughts
        │
        ▼  deep, unbroken sleep
 Overnight BDNF  →  memory consolidation + neural repair  →  wake refreshed

The brakes go fully on, glutamate is dampened, and under deep sleep the day’s learning is consolidated under overnight BDNF, the same mechanism the Sleep series is built on. A clean night with no late-stimulant crash is what makes tomorrow’s Act II possible. The loop closes.

The honest flags: the pieces I'd weight heavily before believing the story

The narrative is seductive because it’s tidy. Reality is messier, and a few pieces above deserve a hard second look:

  • Nightly Fluvoxamine (an SSRI) “to calm the amygdala” is the one I’d push back on hardest. It potently inhibits the liver enzyme CYP1A2 (which metabolises caffeine and melatonin), so it can dramatically amplify both, exactly the compounds this day already uses. SSRIs also blunt drive and libido, directly fighting the protocol’s whole goal. This is not a casual nightly add.
  • High-dose melatonin as an “antioxidant” sits in tension with the Sleep series: melatonin is a chronobiotic, not a hypnotic, and more is not better for sleep. The antioxidant rationale exists but is debated; don’t assume the big dose is helping.
  • A GLP-1 agonist (Liraglutide) purely to suppress hunger for fasting is medicalising a preference; it’s an injectable drug with real GI side effects, not a focus tool.
  • Daily Donepezil and daily stimulants trade long-term tolerance and cholinergic/cardiovascular cost for short-term sharpness, the opposite of the swing-weapon discipline this article argues for.
  • The anabolics and intranasal testosterone belong to the PE protocol, with its own bloodwork and harm-reduction; they are not “cognitive” additions and shouldn’t be reasoned about as if they were.

The Golden Rule that holds the whole day together

Notice what makes the defensible version of this day work: every dose is low, and the inputs are layered, not maxed. Never stack compounding compounds at maximum solo doses. A precursor + a metabolic optimiser + a small breakdown-inhibitor + a calming balancer, each modest, produces a smooth, balanced state; a single megadose shoves you past your inverted-U peak into jitters, crash, and tolerance. This is the same low-dose synergy Golden Rule as the natural stack, and it’s the only reason an integrated day like this could be coherent rather than a chemical pile-up. The maximal day is a map; the Golden Rule is how you’d ever walk a small, safe part of it.

Part 4.2 Takeaways

Key concepts to internalise

  • This article is a catalog, not a protocol. It tells you what each enhanced compound is and what it costs you in risk. Whether to escalate lives in Part 4.0; how to fold one into your base lives in Part 4.3.
  • Most people never need to open this. A dialled natural stack plus good sleep is already winning; the enhanced layer trades worse risk-reward for diminishing returns.
  • Same six pathways, turned up: eugeroics/stimulants (ignition), racetams (acetylcholine), peptides (neurogenesis), Memantine/Mag-threonate (the shield you add because you’re enhancing), neurosteroids (the on-cycle variable), Buspirone/Selank (calm).
  • Modafinil is for the depleted brain, not the fresh one. Amphetamines carry a cardiovascular tax that’s especially bad on cycle.
  • Racetam evidence in healthy adults is thin; they’re choline-dependent (your base covers it, which is exactly why the mixing in 4.3 matters).
  • Dihexa and Phenibut are the two hard stops: a theoretical cancer mechanism with no human data, and a severe-dependence trap, respectively.
  • The Maximal Day is a map, not a menu. The fully-assembled “maxed-out” day exists to show how the pathways relate across a day; you build a fraction of it. And the Golden Rule that makes any of it coherent: low-dose synergy beats max-dosing; never stack compounding compounds at maximum solo doses.

How to read this catalog

  1. Pass the gate first. If you haven’t run the “do you even need this?” gate in Part 4.0 (natural stack maxed, sleep fixed, a measured ceiling), close this article; that’s your real next move.
  2. Read each compound as a what-and-what-it-costs entry, not an instruction. Note the pathway it amplifies and the specific risk in the matrix.
  3. For the how, go to Part 4.3. That’s where the actual recipes live: which natural heavy-layer compound to remove when you add an enhanced one, what runs daily versus cyclically, and the preservation shield (Memantine or lower-risk Mag-L-Threonate/NAC) you add before running any Tier-1 stimulant regularly.
  4. Two compounds are simply off the table: never touch Dihexa or Phenibut. And treat every prescription compound as the controlled substance it legally is.

Up next: how to actually mix it

This catalog tells you what’s on the shelf. The next article, Part 4.3 — The Hybrid Stack, is the one that turns it into a usable protocol: how to fold a single enhanced compound into the natural engine and what to take out when you do (the classic case: dropping caffeine but keeping L-theanine on a modafinil day), plus which experimental compounds can run daily versus only in cycles. Read it before you combine anything. The Sleep series is effectively Part 0 of this one, and the PE neuroprotection chapter is its hormonal sibling.

Disclaimer

This article is educational and is not medical advice. Modafinil, armodafinil, methylphenidate, amphetamines, donepezil, galantamine, memantine, and buspirone are prescription medications, several of them controlled substances in Malaysia; obtaining or using them without a prescription is illegal and unsafe. Racetams, Noopept, Semax, Selank, Bromantane, and Dihexa are research chemicals without established long-term human safety data; Cerebrolysin is an injectable medical drug. Dihexa carries a theoretical oncological risk and has no human safety data; Phenibut carries severe dependence and withdrawal risk. Stimulants are dangerous in anyone with cardiovascular disease or on exogenous androgens. Nothing here is a recommendation to obtain or use any scheduled or research compound. Consult a qualified doctor.

Sources & references

Footnotes

  1. Battleday, R.M. & Brem, A.-K. (2015), “Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review,” European Neuropsychopharmacology 25(11):1865–1881; with Repantis, D. et al. (2010), Pharmacological Research 62(3):187–206. Robust under sleep deprivation, modest (mainly attention) in well-rested subjects. PubMed 26381811. ↩

  2. On racetams: piracetam’s clinical evidence is concentrated in elderly/cognitively-impaired populations, with meta-analysis showing no clear memory benefit over placebo even there, and little evidence of benefit in healthy adults; aniracetam shows effects in impaired but not healthy subjects. See Examine.com’s piracetam research review and the cited systematic reviews (e.g. systematic review and meta-analysis of piracetam in adults with memory impairment, 2024). Phenylpiracetam is included on the WADA Prohibited List. ↩

  3. Ostrovskaya, R.U. et al. (2008), “The original novel nootropic and neuroprotective agent noopept,” Bulletin of Experimental Biology and Medicine. Noopept increases BDNF/NGF expression in rodent hippocampus; human data limited. On Semax’s BDNF effects, see Dolotov, O.V. et al. (2006), Journal of Neurochemistry. ↩

Graph View

Backlinks